Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Evans

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Virology|July 7, 2021
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected CellsSai Priya Anand, Shilei Ding, William D Tolbert, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Medicine|November 18, 2015
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaAngelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, et al.
Journal of Virology|March 28, 2023
Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIV<sub>mac251</sub> AcquisitionJames D Stamos, Mohammad Arif Rahman, Giacomo Gorini, et al.
Plos Pathogens|January 22, 2024
Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challengeMichael W Grunst, Hwi Min Gil, Andres G Grandea, et al.
Plos Pathogens|July 22, 2017
Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaquesMauricio A Martins, Young C Shin, Lucas Gonzalez-Nieto, et al.
Science (New York, N.Y.)|February 29, 2024
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaquesSo-Yon Lim, Jina Lee, Christa E Osuna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entryQingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology|August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyMattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Journal of Virology|April 7, 2025
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaquesElise G Viox, Jonathan Richard, Andres G Grandea, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Virology|July 7, 2021
Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected CellsSai Priya Anand, Shilei Ding, William D Tolbert, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Medicine|November 18, 2015
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaAngelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, et al.
Journal of Virology|March 28, 2023
Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIV<sub>mac251</sub> AcquisitionJames D Stamos, Mohammad Arif Rahman, Giacomo Gorini, et al.
Plos Pathogens|January 22, 2024
Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challengeMichael W Grunst, Hwi Min Gil, Andres G Grandea, et al.
Plos Pathogens|July 22, 2017
Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaquesMauricio A Martins, Young C Shin, Lucas Gonzalez-Nieto, et al.
Science (New York, N.Y.)|February 29, 2024
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaquesSo-Yon Lim, Jina Lee, Christa E Osuna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2014
Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entryQingsheng Li, Ming Zeng, Lijie Duan, et al.
Journal of Virology|August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyMattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Journal of Virology|April 7, 2025
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaquesElise G Viox, Jonathan Richard, Andres G Grandea, et al.
Pageof 10